S
Sean P. J. Whelan
Researcher at Washington University in St. Louis
Publications - 194
Citations - 22049
Sean P. J. Whelan is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Vesicular stomatitis virus & Virus. The author has an hindex of 58, co-authored 171 publications receiving 15387 citations. Previous affiliations of Sean P. J. Whelan include University of Pittsburgh & University of Alabama.
Papers
More filters
Journal ArticleDOI
Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus
TL;DR: The principles of transcriptional regulation have been utilized to develop a new paradigm for systematic attenuation of virulence to develop live attenuated viral vaccines.
Journal ArticleDOI
Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA
TL;DR: Compared the template properties of a subgenomic RNA that contained the authentic 5' and 3' ends of the vesicular stomatitis virus genome with those of RNAs in which the wild-type termini were engineered to extend their complementarity, it is demonstrated that the extent of terminal complementarity rather than its exact sequence is a major determinant of whether the template predominantly directs transcription or replication.
Journal ArticleDOI
Amino Acid Residues within Conserved Domain VI of the Vesicular Stomatitis Virus Large Polymerase Protein Essential for mRNA Cap Methyltransferase Activity
TL;DR: Data show that the predicted MTase active-site residues K1651, D1762, K1795, and E1833 within domain VI of the VSV L protein are essential for mRNA cap methylation, and a model of mRNA processing consistent with these data is presented.
Journal ArticleDOI
Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome.
Sean P. J. Whelan,Gail W. Wertz +1 more
TL;DR: By applying UV transcriptional mapping to engineered variants of vesicular stomatitis virus, it is discovered that, in infected cells, transcription and replication are controlled by initiation at different positions on the viral genome.
Posted ContentDOI
Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2
Parakkal Deepak,Wooseob Kim,Michael A. Paley,M. Yang,Alexander Carvidi,A. A. El-Qunni,Alem Haile,Kuan-lin Huang,Baylee Kinnett,Mariel J. Liebeskind,Zhuoming Liu,Lily E McMorrow,D. Paez,Dana C. Perantie,Rebecca E Schriefer,S. E. Sides,Mahima Thapa,Maté Gergely,Suha Abushamma,Michael K. Klebert,Lynne M. Mitchell,Darren Nix,Jonathan Graf,Kristopher Taylor,Salim Chahin,Matthew A. Ciorba,Patricia P. Katz,Mehrdad Matloubian,Jane A. O’Halloran,Rachel M. Presti,Gregory F. Wu,Sean P. J. Whelan,William Buchser,Lianne S. Gensler,Mary C. Nakamura,Ali H. Ellebedy,Alfred H.J. Kim +36 more
TL;DR: In this article, a prospective assessment of mRNA-based vaccine immunogenicity in 133 adults with chronic inflammatory diseases (CID) and 53 immunocompetent controls was conducted, where participants over 18 years of age were collected before initial immunization and 1-2 weeks after the second immunization.